Skip to main content

In this section you will find articles and reports of interest that we feel add value and great insight to help shape the future of health.

The Federal Council’s health policy strategy 2020–2030

With its health policy strategy for 2020–2030, the Federal Council intends to further improve the system, so that everyone in Switzerland can continue to benefit from high-quality, affordable healthcare. Health2030 sets a framework for action in health policy, providing guidance for all health system actors.

Read it here.


Pharma Location Switzerland 2030

With the strategy report ‘Pharma Location Switzerland 2030’, Interpharma outlines a way in which Switzerland can remain Europe’s leading pharmaceutical location in 2030 (German and French).

Read it here.


Potentials of Digital Transformation

Identifying and Successfully Implementing Digital Potential. Internet of Things, artificial intelligence, blockchains, 3D printing und augmented reality – the sheer number of new technologies for the digital transformation is endless and so is the amount of promises linked to them: increase of efficiency, cost reduction, easier collaboration, new market potentials and with that new customer segments and additional sources of income.

Read it here.


Visualizing an Ethics Framework: A Method to Create Interactive Knowledge Visualizations From Health Policy Documents

This study sheds light on how to develop an interactive visualization from a policy document and lays the foundation to innovate ethical framework dissemination practices on the Web.

Read it here.


Approaching 1,000 Mental Health Startups in 2020

There is seemingly endless white space in this market today, and a flood of entrepreneurs looking to enter, not only because of the market size, but because the reduction in stigma has made them more comfortable with solving something so personal.

Read it here.


Innovative Funding Models For Treatment Of Cancer And Other High-Cost Chronic Noncommunicable Diseases

This study identifies and assesses innovative funding models for cancer treatment and other high-cost chronic NCDs across Asia Pacific, Latin America, Europe, Africa and the Middle East.

Read it here.